Efficient control strategies against phytoplasma vectoring psyllids will be established by the help of molecular markers to study their life cycle, by determining the transmission parameters and by developing disturbation strategies.
The aim is to develop a new artificial intervertebral disc. For that a new hydrogel-based reinforced material will be developed using new technology. The disc shall be suitable for use with a minimally invasive approach.
To develop a platform for the biocatalytic conversion of biosystemic acids with naturally derived oil compounds. These biocatalytic conversions will involve enzymes in a form applicable in an industrial process.
We propose the development of new nanomaterials that will allow new methods for cancer treatments with less side effects and in situ adjustable efficacy.
Aims at developing new families of molecules to be used for in vivo dna surgery, as a therapeutic approach to genetic and viral diseases, or to be used as industrial tools.
Production of antibodies against novel gene products(proteins) is essential, but there are often obstacles to studying brain function or disease. Commercial availability of sets of antibodies will be useful to many brain research facilities.
Development and industrial-scale application of a patentable procedure for objectively and reliably guaranteeing the hybrid nature of oil palm seeds, using molecular biology techniques.
In previous projects, efficient micropropagation, regeneration and transformation procedures have been developed. In this project we intend to commercially micropropagate elite apricot cultivars and regenerate transformed apricot plantlets
Combining molecular technologies which permit identification - quantification of micro-organisms without cultivation and a decision diagram suggested by hygienists, whereby emerging nosocomial pathogens could be more rapidly detected and eradicated from the health area.
The goal of the project is to develop improved disease therapies based on a new generation of therapeutic proteins